SCHEMBL18257581

SCHEMBL18257581

COC(=O)Cc1nocc1-c1ccccc1NC(=O)OC(C)(C)C

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 2/20 0.38
CTSS P25774 1/20 0.37
CTSK P43235 1/20 0.37
HSP90AA1 P07900 1/20 0.37
HSP90AB1 P08238 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
BRD9 Q9H8M2 1/20 0.36
TRPV1 Q8NER1 1/20 0.36
TDP2 O95551 1/20 0.35
RXFP1 Q9HBX9 1/20 0.35
METAP1 P53582 1/20 0.35
BRD4 O60885 1/20 0.35
LMNA P02545 1/20 0.35
POLB P06746 1/20 0.35
CNR2 P34972 1/20 0.35
PTPRC P08575 3/20 0.34
PTPN13 Q12923 1/20 0.34
MALT1 Q9UDY8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18257530 0.90 BRD9 (0.39) IDO1HSP90AA1HSP90AB1BRD9TRPV1
SCHEMBL18257531 0.87 TTK (0.38) IDO1CTSSCTSKHSP90AA1HSP90AB1
SCHEMBL16748920 0.81 TDP2 (0.40) IDO1HSP90AA1HSP90AB1BRD9TRPV1
SCHEMBL29324607 0.74 SMN1; SMN2 (0.43) SMN1; SMN2BRD9RXFP1METAP1POLB
SCHEMBL4414634 0.71 LMNA (0.48) IDO1HSP90AA1HSP90AB1SMN1; SMN2BRD9
SCHEMBL27983901 0.71 POLB (0.40) IDO1HSP90AA1HSP90AB1BRD9RXFP1
SCHEMBL404007 0.71 TDP2 (0.42) IDO1HSP90AA1HSP90AB1BRD9TDP2
SCHEMBL16748917 0.70 TDP2 (0.42) IDO1HSP90AA1HSP90AB1SMN1; SMN2BRD9
SCHEMBL3783723 0.70 BRD9 (0.47) IDO1HSP90AA1HSP90AB1BRD9TRPV1
SCHEMBL2880191 0.70 LMNA (0.54) HSP90AA1HSP90AB1SMN1; SMN2BRD9RXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2864336-B1 BENZO[B]ISOXAZOLOAZEPINE BROMODOMAIN INHIBITORS AND USES THEREOF CONSTELLATION PHARMACEUTICALS INC (US) 2016-11-23 EP disclosed